Literature DB >> 33040314

Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

Tatiana Barichello1,2,3, Vijayasree Vayalanellore Giridharan4, Gursimrat Bhatti4, Pavani Sayana4, Tejaswini Doifode4, Danielle Macedo5,6, Joao Quevedo4,7,8,9.   

Abstract

Bipolar disorder (BD) is a severe, debilitating psychiatric condition with onset in adolescence or young adulthood and often follows a relapsing and remitting course throughout life. The concept of neuroprogression in BD refers to the progressive path with an identifiable trajectory that takes place with recurrent mood episodes, which eventually leads to cognitive, functional, and clinical deterioration in the course of BD. Understanding the biological basis of neuroprogression helps to explain the subset of BD patients who experience worsening of their disorder over time. Additionally, the study of the neurobiological mechanisms underpinning neuroprogression will help BD staging based on systems biology. Replicated epidemiological studies have suggested inflammatory mechanisms as primary contributors to the neuroprogression of mood disorders. It is known that dysregulated inflammatory/immune pathways are often associated with BD pathophysiology. Hence, in this chapter, we focus on the evidence for the involvement of inflammation and immune regulated pathways in the neurobiological consequences of BD neuroprogression. Herein we put forth the evidence of immune markers from autoimmune disorders, chronic infections, and gut-brain axis that lead to BD neuroprogression. Further, we highlighted the peripheral and central inflammatory components measured along with BD progression.

Entities:  

Keywords:  Bipolar disorder; Host immune response; Inflammation; Neuroprogression

Mesh:

Substances:

Year:  2021        PMID: 33040314     DOI: 10.1007/7854_2020_173

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  134 in total

1.  Mania associated with infliximab.

Authors:  Marni Austin; Yong Chiang Jonathan Tan
Journal:  Aust N Z J Psychiatry       Date:  2012-07       Impact factor: 5.744

2.  3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.

Authors:  Ana Cristina Andreazza; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Julio C Walz; David J Bond; Carlos A Gonçalves; L Trevor Young; Lakshmi N Yatham
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

3.  Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1.

Authors:  Christoph Abé; Carl-Johan Ekman; Carl Sellgren; Predrag Petrovic; Martin Ingvar; Mikael Landén
Journal:  Brain       Date:  2015-09-15       Impact factor: 13.501

4.  Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Authors:  Giovanni Almanzar; Susanne Schwaiger; Brigitte Jenewein; Michael Keller; Dietmar Herndler-Brandstetter; Reinhard Würzner; Diether Schönitzer; Beatrix Grubeck-Loebenstein
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 5.  Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

Authors:  Ziada Ayorech; Derek K Tracy; David Baumeister; Giovanni Giaroli
Journal:  J Affect Disord       Date:  2014-12-12       Impact factor: 4.839

6.  Serum S100B and antioxidant enzymes in bipolar patients.

Authors:  Ana Cristina Andreazza; Carina Cassini; Adriane Ribeiro Rosa; Marina Concli Leite; Lucia M V de Almeida; Patrícia Nardin; Angelo B N Cunha; Keila Maria Ceresér; Aida Santin; Carmem Gottfried; Mirian Salvador; Flavio Kapczinski; Carlos Alberto Gonçalves
Journal:  J Psychiatr Res       Date:  2006-09-07       Impact factor: 4.791

7.  Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.

Authors:  Izabela Guimarães Barbosa; Natalia Pessoa Rocha; Rodrigo Barreto Huguet; Rodrigo A Ferreira; João Vinícius Salgado; Livia A Carvalho; Carmine M Pariante; Antônio Lúcio Teixeira
Journal:  J Affect Disord       Date:  2012-01-16       Impact factor: 4.839

8.  Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.

Authors:  Ya-Mei Bai; Tung-Ping Su; Shih-Jen Tsai; Chiou Wen-Fei; Cheng-Ta Li; Tu Pei-Chi; Chen Mu-Hong
Journal:  J Affect Disord       Date:  2014-05-21       Impact factor: 4.839

9.  T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis.

Authors:  L L Altshuler; J G Curran; P Hauser; J Mintz; K Denicoff; R Post
Journal:  Am J Psychiatry       Date:  1995-08       Impact factor: 18.112

Review 10.  Cytokines in bipolar disorder: paving the way for neuroprogression.

Authors:  Izabela Guimarães Barbosa; Moisés Evandro Bauer; Rodrigo Machado-Vieira; Antonio Lucio Teixeira
Journal:  Neural Plast       Date:  2014-09-09       Impact factor: 3.599

View more
  3 in total

Review 1.  Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.

Authors:  Joao E Rodrigues; Ana Martinho; Vítor Santos; Catia Santa; Nuno Madeira; Maria J Martins; Carlos N Pato; Antonio Macedo; Bruno Manadas
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder.

Authors:  Teodor T Postolache; Deborah R Medoff; Clayton H Brown; Li Juan Fang; Sanjaya K Upadhyaya; Christopher A Lowry; Michael Miller; Julie A Kreyenbuhl
Journal:  Pteridines       Date:  2021-09-23       Impact factor: 0.581

3.  White Matter Correlates of Early-Onset Bipolar Illness and Predictors of One-Year Recurrence of Depression in Adults with Bipolar Disorder.

Authors:  João Paulo Lima Santos; Michele Bertocci; Genna Bebko; Tina Goldstein; Tae Kim; Satish Iyengar; Lisa Bonar; MaryKay Gill; John Merranko; Anastasia Yendiki; Boris Birmaher; Mary L Phillips; Amelia Versace
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.